51. The rs1468615 T>C in ABCB4 confers protection against gallstone disease but not against severe liver disease. (March 2023) Authors: Tavaglione, F.; Jamialahmadi, O.; De Vincentis, A.; Gallo, P.; Incalzi, R. Antonelli; Picardi, A.; Romeo, S.; Vespasiani-Gentilucci, U. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
52. TM6SF2 silencing impairs lipid metabolism and trafficking in HepG2 cells carrying the I148M PNPLA3 variant and MBOAT7 deletion. (February 2019) Authors: Longo, M.; Meroni, M.; Rametta, R.; Erconi, V.; Romeo, S.; Fracanzani, A.L.; Valenti, L.; Dongiovanni, P. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
53. Transcriptomics highlights interleukin-32 a novel biomarker showing higher accuracy in carriers of the pnpla3 i148m variant. (February 2019) Authors: Baselli, G.A.; Dongiovanni, P.; Rametta, R.; Meroni, M.; Pelusi, S.; Maggioni, M.; Badiali, S.; Pingitore, P.; Montalcini, T.; Prati, D.; Rossi, G.; Fracanzani, A.; Mancina, R.M.; Romeo, S.; Valenti, L.V.C. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
54. Validation of Interleukin-32 as a new circulating fatty liver biomarker. (February 2020) Authors: Baselli, G.A.; Dongiovanni, P.; Rametta, R.; Meroni, M.; Pelusi, S.; Maggioni, M.; Badiali, S.; Pingitore, P.; Maurotti, S.; Montalcini, T.; Taliento, A.E.; Prati, D.; Rossi, G.; Fracanzani, A.L.; Mancina, R.M.; Romeo, S.; Valenti, L.V.C. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗